Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphatic Vessels | 2 | 2010 | 143 | 0.380 |
Why?
|
| Embolism | 1 | 2010 | 59 | 0.370 |
Why?
|
| Receptors, Notch | 1 | 2010 | 383 | 0.300 |
Why?
|
| Inflammatory Breast Neoplasms | 1 | 2010 | 509 | 0.260 |
Why?
|
| Neoplastic Stem Cells | 2 | 2009 | 1443 | 0.230 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2012 | 2359 | 0.190 |
Why?
|
| Spheroids, Cellular | 2 | 2010 | 222 | 0.160 |
Why?
|
| Transplantation, Heterologous | 2 | 2010 | 1082 | 0.150 |
Why?
|
| Transcription Factors | 4 | 2012 | 5270 | 0.140 |
Why?
|
| Estrogen Receptor alpha | 2 | 2010 | 701 | 0.120 |
Why?
|
| Breast Neoplasms | 5 | 2010 | 15694 | 0.110 |
Why?
|
| DNA Damage | 2 | 2012 | 1954 | 0.110 |
Why?
|
| Cell Line, Tumor | 8 | 2012 | 14551 | 0.110 |
Why?
|
| Biomarkers, Tumor | 3 | 2010 | 10331 | 0.100 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2012 | 287 | 0.100 |
Why?
|
| Receptor, Notch3 | 1 | 2010 | 31 | 0.100 |
Why?
|
| Cytidine Deaminase | 1 | 2010 | 83 | 0.090 |
Why?
|
| Cadherins | 2 | 2010 | 660 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 3 | 2010 | 3203 | 0.090 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2009 | 103 | 0.090 |
Why?
|
| Inflammation | 2 | 2009 | 2522 | 0.080 |
Why?
|
| Gene Targeting | 1 | 2010 | 292 | 0.080 |
Why?
|
| Neoplasm Transplantation | 2 | 2009 | 1519 | 0.080 |
Why?
|
| Tumor Escape | 1 | 2010 | 251 | 0.080 |
Why?
|
| Transfection | 2 | 2010 | 2944 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2012 | 4821 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2010 | 3536 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2009 | 614 | 0.080 |
Why?
|
| Cell Polarity | 1 | 2008 | 208 | 0.070 |
Why?
|
| Apoptosis | 2 | 2012 | 7591 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 891 | 0.070 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2010 | 607 | 0.070 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2010 | 1016 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2010 | 11965 | 0.060 |
Why?
|
| Neoplasm Metastasis | 2 | 2010 | 5112 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 7548 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 3154 | 0.050 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2010 | 1763 | 0.050 |
Why?
|
| Snail Family Transcription Factors | 2 | 2010 | 120 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 5159 | 0.040 |
Why?
|
| Mice | 5 | 2010 | 34495 | 0.040 |
Why?
|
| Cell Cycle | 2 | 2012 | 2084 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 2216 | 0.030 |
Why?
|
| Neoplasms | 2 | 2012 | 15193 | 0.030 |
Why?
|
| Female | 6 | 2010 | 141928 | 0.030 |
Why?
|
| Animals | 5 | 2010 | 59536 | 0.030 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 342 | 0.030 |
Why?
|
| Humans | 8 | 2012 | 261506 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 110 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2010 | 157 | 0.020 |
Why?
|
| Retinal Dehydrogenase | 1 | 2009 | 91 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2010 | 163 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 842 | 0.020 |
Why?
|
| Plasmacytoma | 1 | 2010 | 111 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2010 | 161 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 611 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 666 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2010 | 675 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 1062 | 0.020 |
Why?
|
| Mesoderm | 1 | 2010 | 404 | 0.020 |
Why?
|
| Epithelium | 1 | 2010 | 720 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2009 | 905 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 671 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2008 | 869 | 0.020 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2009 | 362 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2009 | 1053 | 0.020 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2010 | 494 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 1077 | 0.020 |
Why?
|
| Plasmids | 1 | 2008 | 837 | 0.020 |
Why?
|
| Estradiol | 1 | 2010 | 748 | 0.020 |
Why?
|
| DNA Primers | 1 | 2008 | 1399 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2008 | 771 | 0.020 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 612 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2009 | 1869 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 2314 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 1408 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2010 | 8873 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2010 | 1506 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2009 | 2450 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 3639 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2010 | 1678 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2010 | 1818 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 2508 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 2054 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 4143 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 3981 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 4917 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2009 | 4804 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 3101 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 6089 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 2045 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2010 | 2819 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 4078 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 6150 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 3552 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2009 | 7226 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 32848 | 0.010 |
Why?
|